TPM4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.939400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.244800E-01
Normal-vs-Stage2
9.995400E-01
Normal-vs-Stage3
9.154000E-01
Normal-vs-Stage4
9.607200E-01
Stage1-vs-Stage2
1.180200E-01
Stage1-vs-Stage3
2.726000E-01
Stage1-vs-Stage4
2.073200E-01
Stage2-vs-Stage3
8.394200E-01
Stage2-vs-Stage4
9.418600E-01
Stage3-vs-Stage4
9.326000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.685000E-01
Normal-vs-AfricanAmerican
6.859200E-01
Normal-vs-Asian
9.431000E-01
Caucasian-vs-AfricanAmerican
6.715200E-01
Caucasian-vs-Asian
8.741000E-01
AfricanAmerican-vs-Asian
6.441600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.714800E-01
Normal-vs-Female
9.287400E-01
Male-vs-Female
7.328800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.067200E-01
Normal-vs-Age(41-60Yrs)
7.768200E-01
Normal-vs-Age(61-80Yrs)
7.908200E-01
Normal-vs-Age(81-100Yrs)
7.638000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.882000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.418000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.055840E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.938500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.806600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.416200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.709400E-01
Normal-vs-Daily Drinker
5.413600E-01
Normal-vs-Weekly Drinker
7.058400E-01
Normal-vs-Occasional Drinker
8.307600E-01
Normal-vs-Social Drinker
8.537000E-01
Non Drinker-vs-Daily Drinker
7.571200E-01
Non Drinker-vs-Weekly Drinker
6.849600E-02
Non Drinker-vs-Occasional Drinker
5.850800E-01
Non Drinker-vs-Social Drinker
5.367000E-01
Daily Drinker-vs-Weekly Drinker
7.400400E-02
Daily Drinker-vs-Occasional Drinker
4.762600E-01
Daily Drinker-vs-Social Drinker
4.428600E-01
Weekly Drinker-vs-Occasional Drinker
2.970800E-01
Weekly Drinker-vs-Social Drinker
3.320400E-01
Occasional Drinker-vs-Social Drinker
9.474200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.325000E-01
Normal-vs-Grade 2
8.439800E-02
Normal-vs-Grade 3
2.230200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.14969999999814E-05
Grade 1-vs-Grade 3
3.499000E-03
Grade 1-vs-Grade 4
7.325000E-01
Grade 2-vs-Grade 3
7.427800E-01
Grade 2-vs-Grade 4
8.439800E-02
Grade 3-vs-Grade 4
2.230200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.420600E-01
Normal-vs-NonDiabetic
8.531000E-01
Diabetic-vs-NonDiabetic
8.755600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.990600E-01
Normal-vs-NoPancreatitis
8.379600E-01
Pancreatitis-vs-NoPancreatitis
5.120800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.584000E-01
Normal-vs-N1
9.785600E-01
N0-vs-N1
1.135630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.382200E-01
Normal-vs-TP53-NonMutant
1.678950E-01
TP53-Mutant-vs-TP53-NonMutant
2.847200E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
